MedMira Inc. (MMIRF)
OTCMKTS · Delayed Price · Currency is USD
0.0133
0.00 (0.00%)
Feb 5, 2026, 4:00 PM EST
MedMira Market Cap
MedMira has a market cap or net worth of $36.06 million as of February 12, 2026. Its market cap has decreased by -11.58% in one year.
Market Cap
36.06M
Enterprise Value
48.68M
Revenue
166.26K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.01
Market Cap Chart
Since June 30, 2000, MedMira's market cap has decreased from 55.18M to 36.06M, a decrease of -34.65%. That is a compound annual growth rate of -1.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 10, 2026 | 36.06M | 8.41% |
| Dec 31, 2025 | 33.27M | -28.20% |
| Dec 31, 2024 | 46.33M | -20.24% |
| Dec 29, 2023 | 58.09M | 40.91% |
| Dec 30, 2022 | 41.23M | -62.60% |
| Dec 31, 2021 | 110.23M | -12.93% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| VitaSpring Biomedical | 51.78M |
| Vicapsys Life Sciences | 48.56M |
| Arch Biopartners | 43.72M |
| ZIVO Bioscience | 40.17M |
| Cell Source | 38.23M |
| Harvard Apparatus Regenerative Technology | 31.12M |
| Oncotelic Therapeutics | 27.82M |
| EOM Pharmaceuticals Holdings | 22.63M |